{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:51:19Z","timestamp":1790207479651,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03110-6","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:52:50Z","timestamp":1772596370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus"],"prefix":"10.1186","volume":"25","author":[{"given":"Mauro","family":"Gitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Filiberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Pasquale","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Luca","family":"Gurgoglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Frazzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Calamita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Luciano","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Reimers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Regazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mangieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Latib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio G.","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmo","family":"Godino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"10397","key":"3110_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"issue":"6","key":"3110_CR2","doi-asserted-by":"publisher","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","volume":"12","author":"AN Nowbar","year":"2019","unstructured":"Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):e005375. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005375.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"3110_CR3","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.4244\/EIJ-D-23-00628","volume":"20","author":"D del Val","year":"2024","unstructured":"del Val D, Berta B, Roleder T, et al. Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial. EuroIntervention. 2024;20(11):e707\u201317. https:\/\/doi.org\/10.4244\/EIJ-D-23-00628.","journal-title":"EuroIntervention"},{"issue":"24","key":"3110_CR4","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"The BARI 2D Study Group","year":"2009","unstructured":"The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503\u201315. https:\/\/doi.org\/10.1056\/NEJMoa0805796.","journal-title":"N Engl J Med"},{"issue":"4","key":"3110_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/CCD.31179","volume":"104","author":"A Roumeliotis","year":"2024","unstructured":"Roumeliotis A, Siasos G, Dangas G, et al. Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention. Catheter Cardiovasc Interv. 2024;104(4):723\u201332. https:\/\/doi.org\/10.1002\/CCD.31179.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"3110_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/J.JACC.2014.06.1182","volume":"64","author":"GD Dangas","year":"2014","unstructured":"Dangas GD, Farkouh ME, Sleeper LA, et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol. 2014;64(12):1189\u201397. https:\/\/doi.org\/10.1016\/J.JACC.2014.06.1182.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3110_CR7","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/J.JSCAI.2023.100607","volume":"2","author":"A Thomas","year":"2023","unstructured":"Thomas A, Gitto M, Shah S, et al. Antiplatelet strategies following PCI: A review of trials informing current and future therapies. J Soc Cardiovasc Angiography Interventions. 2023;2(3):100607. https:\/\/doi.org\/10.1016\/J.JSCAI.2023.100607.","journal-title":"J Soc Cardiovasc Angiography Interventions"},{"key":"3110_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.PCAD.2025.07.005","author":"PP Leone","year":"2025","unstructured":"Leone PP, Gitto M, Gao C, Sanz S\u00e1nchez J, Latib A, Colombo A. Rethinking coronary artery metal implants. Prog Cardiovasc Dis Published Online. 2025. https:\/\/doi.org\/10.1016\/J.PCAD.2025.07.005.","journal-title":"Prog Cardiovasc Dis Published Online"},{"issue":"4","key":"3110_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/J.JCIN.2023.12.021","volume":"17","author":"A Camaj","year":"2024","unstructured":"Camaj A, Leone PP, Kini A, Sharma SK. Sirolimus- vs Paclitaxel-Coated balloons: it is only the start. JACC Cardiovasc Interv. 2024;17(4):580. https:\/\/doi.org\/10.1016\/J.JCIN.2023.12.021.","journal-title":"JACC Cardiovasc Interv"},{"issue":"41","key":"3110_CR10","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1093\/EURHEARTJ\/EHAD215","volume":"44","author":"A Colombo","year":"2023","unstructured":"Colombo A, Leone PP. Redefining the way to perform percutaneous coronary intervention: a view in search of evidence. Eur Heart J. 2023;44(41):4321\u20133. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAD215.","journal-title":"Eur Heart J"},{"issue":"11","key":"3110_CR11","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.4244\/EIJ-D-23-00502","volume":"19","author":"PP Leone","year":"2023","unstructured":"Leone PP, Oliva A, Regazzoli D, et al. Immediate and follow-up outcomes of drug-coated balloon angioplasty in de Novo long lesions on large coronary arteries. EuroIntervention. 2023;19(11):e923\u20135. https:\/\/doi.org\/10.4244\/EIJ-D-23-00502.","journal-title":"EuroIntervention"},{"key":"3110_CR12","doi-asserted-by":"publisher","first-page":"e013232","DOI":"10.1161\/CIRCINTERVENTIONS.123.013232","volume":"24","author":"M Gitto","year":"2023","unstructured":"Gitto M, Sticchi A, Chiarito M, et al. Drug-Coated balloon angioplasty for de Novo lesions on the left anterior descending Artery. Circ cardiovasc interv. Published Online Oct. 2023;24:e013232. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.013232.","journal-title":"Published Online Oct"},{"key":"3110_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.AMJCARD.2024.12.008","volume":"239","author":"M Gitto","year":"2024","unstructured":"Gitto M, Leone PP, Gioia F, et al. Coronary artery dissection in Drug-Coated balloon angioplasty: Incidence, Predictors, and clinical outcomes. Am J Cardiol. 2024;239:28\u201335. https:\/\/doi.org\/10.1016\/J.AMJCARD.2024.12.008.","journal-title":"Am J Cardiol"},{"issue":"3","key":"3110_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/J.JCIN.2022.10.049","volume":"16","author":"ES Shin","year":"2023","unstructured":"Shin ES, Jun EJ, Kim S, et al. Clinical impact of Drug-Coated Balloon\u2013Based percutaneous coronary intervention in patients with multivessel coronary artery disease. JACC Cardiovasc Interv. 2023;16(3):292\u20139. https:\/\/doi.org\/10.1016\/J.JCIN.2022.10.049.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"3110_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/J.JCIN.2022.09.054","volume":"16","author":"PP Leone","year":"2023","unstructured":"Leone PP, Mangieri A, Regazzoli D, et al. Drug-Coated balloon angioplasty guided by postpercutaneous coronary intervention pressure gradient: the REDUCE-STENT retrospective registry. Cardiovasc Interventions. 2023;16(3):363\u20135. https:\/\/doi.org\/10.1016\/J.JCIN.2022.09.054.","journal-title":"Cardiovasc Interventions"},{"key":"3110_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHAF002","author":"S Fezzi","year":"2025","unstructured":"Fezzi S, Giacoppo D, Fahrni G et al Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study. Eur Heart J 2025. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAF002.","journal-title":"Eur Heart J"},{"issue":"21","key":"3110_CR17","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/J.JACC.2020.04.006","volume":"75","author":"D Giacoppo","year":"2020","unstructured":"Giacoppo D, Alfonso F, Xu B, et al. Drug-Coated balloon angioplasty versus Drug-Eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75(21):2664\u201378. https:\/\/doi.org\/10.1016\/J.JACC.2020.04.006.","journal-title":"J Am Coll Cardiol"},{"key":"3110_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJCARD.2025.07.004","author":"PP Leone","year":"2025","unstructured":"Leone PP, Calamita G, Gitto M et al Sirolimus- versus paclitaxel-coated balloons for treatment of coronary artery disease. Am J Cardiol. 2025. https:\/\/doi.org\/10.1016\/J.AMJCARD.2025.07.004.","journal-title":"Am J Cardiol"},{"issue":"14","key":"3110_CR19","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/J.JCIN.2023.05.005","volume":"16","author":"B Cortese","year":"2023","unstructured":"Cortese B, Testa L, Heang TM, et al. Sirolimus-Coated balloon in an All-Comer population of coronary artery disease patients: the EASTBOURNE prospective registry. JACC Cardiovasc Interv. 2023;16(14):1794\u2013803. https:\/\/doi.org\/10.1016\/J.JCIN.2023.05.005.","journal-title":"JACC Cardiovasc Interv"},{"key":"3110_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/S00392-025-02664-X","author":"F Tartaglia","year":"2025","unstructured":"Tartaglia F, Gitto M, Leone PP et al. Validation of complex PCI criteria in drug-coated balloon angioplasty. Clin Res Cardiol. 2025. https:\/\/doi.org\/10.1007\/S00392-025-02664-X","journal-title":"Clin Res Cardiol"},{"key":"3110_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.IJCARD.2018.02.014","volume":"260","author":"C Godino","year":"2018","unstructured":"Godino C, Beneduce A, Ferrante G, et al. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comers stent rEgistry). Int J Cardiol. 2018;260:36\u201341. https:\/\/doi.org\/10.1016\/J.IJCARD.2018.02.014.","journal-title":"Int J Cardiol"},{"key":"3110_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/J.IJCARD.2016.03.088","volume":"214","author":"A Colombo","year":"2016","unstructured":"Colombo A, Godino C, Donahue M, et al. One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry). Int J Cardiol. 2016;214:113\u201320. https:\/\/doi.org\/10.1016\/J.IJCARD.2016.03.088.","journal-title":"Int J Cardiol"},{"issue":"7","key":"3110_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4244\/EIJ-D-18-00148","volume":"14","author":"G Sardella","year":"2018","unstructured":"Sardella G, Stefanini GG, Briguori C, et al. Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. EuroIntervention. 2018;14(7):772\u20139. https:\/\/doi.org\/10.4244\/EIJ-D-18-00148.","journal-title":"EuroIntervention"},{"key":"3110_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.CARREV.2024.07.024","volume":"74","author":"A Mangieri","year":"2025","unstructured":"Mangieri A, Testa L, Heang TM, et al. Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: post hoc analysis from the prospective EASTBOURNE registry. Cardiovasc Revasc Med. 2025;74:52\u20136. https:\/\/doi.org\/10.1016\/J.CARREV.2024.07.024.","journal-title":"Cardiovasc Revasc Med"},{"issue":"24","key":"3110_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289\/FORMAT\/EPUB","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, et al. Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation. 2018;137(24):2635\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029289\/FORMAT\/EPUB.","journal-title":"Circulation"},{"issue":"3","key":"3110_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/J.JACC.2016.10.060","volume":"69","author":"MC Elze","year":"2017","unstructured":"Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69(3):345\u201357. https:\/\/doi.org\/10.1016\/J.JACC.2016.10.060.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3110_CR27","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.4244\/EIJ-D-20-00487","volume":"16","author":"GG Stefanini","year":"2020","unstructured":"Stefanini GG, Alfonso F, Barbato E, et al. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI. EuroIntervention. 2020;16(11):e875\u201390. https:\/\/doi.org\/10.4244\/EIJ-D-20-00487.","journal-title":"EuroIntervention"},{"issue":"2","key":"3110_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/CCD.29164","volume":"96","author":"M Chiarito","year":"2020","unstructured":"Chiarito M, Mehran R. Drug-eluting stents in diabetic patients: are we still treading water? Catheter Cardiovasc Interv. 2020;96(2):253\u20134. https:\/\/doi.org\/10.1002\/CCD.29164.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"3110_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/J.JACASI.2021.07.009","volume":"1","author":"Y Yang","year":"2021","unstructured":"Yang Y, Hyun J, Lee J, et al. Effectiveness and safety of contemporary Drug-Eluting stents in patients with diabetes mellitus. JACC Asia. 2021;1(2):173\u201384. https:\/\/doi.org\/10.1016\/J.JACASI.2021.07.009.","journal-title":"JACC Asia"},{"issue":"14","key":"3110_CR30","doi-asserted-by":"publisher","first-page":"e019834","DOI":"10.1161\/JAHA.120.019834","volume":"10","author":"YJ Jeong","year":"2021","unstructured":"Jeong YJ, Ahn JM, Hyun J, et al Ten-year outcomes after Drug-Eluting stents or bypass surgery for left main coronary disease in patients with and without diabetes mellitus: the PRECOMBAT extended Follow-Up study. J Am Heart Assoc. 2021;10(14):e019834. https:\/\/doi.org\/10.1161\/JAHA.120.019834.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"3110_CR31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/EURHEARTJ\/EHAB790","volume":"43","author":"R Romaguera","year":"2022","unstructured":"Romaguera R, Salinas P, Gomez-Lara J, et al. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial. Eur Heart J. 2022;43(13):1320\u201330. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB790.","journal-title":"Eur Heart J"},{"issue":"1","key":"3110_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.CARREV.2016.12.008","volume":"18","author":"F Giannini","year":"2017","unstructured":"Giannini F, Latib A, Jabbour RJ, et al. Comparison of Paclitaxel drug-eluting balloon and Paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial. Cardiovasc Revasc Med. 2017;18(1):4\u20139. https:\/\/doi.org\/10.1016\/J.CARREV.2016.12.008.","journal-title":"Cardiovasc Revasc Med"},{"issue":"10261","key":"3110_CR33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA, et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396(10261):1504\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(20)32173-5.","journal-title":"Lancet"},{"key":"3110_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2022.1036766","author":"K Li","year":"2022","unstructured":"Li K, Cui K, Dan X, Feng J, Pu X The comparative short-term efficacy and safety of drug-coated balloon vs. drug-eluting stent for treating small-vessel coronary artery lesions in diabetic patients. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/FPUBH.2022.1036766.","journal-title":"Front Public Health"},{"key":"3110_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/J.AMJCARD.2023.08.113","volume":"206","author":"M Verdoia","year":"2023","unstructured":"Verdoia M, Zilio F, Gioscia R, et al. Prognostic impact of Drug-Coated balloons in patients with diabetes mellitus: A Propensity-Matched study. Am J Cardiol. 2023;206:73\u20138. https:\/\/doi.org\/10.1016\/J.AMJCARD.2023.08.113.","journal-title":"Am J Cardiol"},{"issue":"2","key":"3110_CR36","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.4244\/EIJ-E-23-00034","volume":"20","author":"A Colombo","year":"2024","unstructured":"Colombo A, Leone PP, Ploumen EH, von Birgelen C. Drug-coated balloons as a first choice for patients with de Novo lesions: pros and cons. EuroIntervention. 2024;20(2):e120\u20132. https:\/\/doi.org\/10.4244\/EIJ-E-23-00034.","journal-title":"EuroIntervention"},{"key":"3110_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-025-05441-Y","author":"Y Gao","year":"2025","unstructured":"Gao Y, Gu N, Zhou Y, Wang Y, Zhao R, Shi B Study on the relationship between in-stent neoatherosclerosis and chronic kidney disease: an optical coherence tomography study. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/S41598-025-05441-Y.","journal-title":"Sci Rep"},{"issue":"11","key":"3110_CR38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/J.JACC.2015.06.1334","volume":"66","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: Everolimus-Eluting stents versus coronary artery bypass graft surgery. J Am Coll Cardiol. 2015;66(11):1209\u201320. https:\/\/doi.org\/10.1016\/J.JACC.2015.06.1334.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3110_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/EURHEARTJ\/EHZ850","volume":"41","author":"S Torii","year":"2020","unstructured":"Torii S, Jinnouchi H, Sakamoto A, et al. Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: impact on healing. Eur Heart J. 2020;41(6):786\u2013A796. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ850.","journal-title":"Eur Heart J"},{"issue":"16","key":"3110_CR40","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4244\/EIJ-D-19-00296","volume":"16","author":"MG Kong","year":"2021","unstructured":"Kong MG, Han JK, Kang JH, et al. Clinical outcomes of long stenting in the drug-eluting stent era: Patient-level pooled analysis from the GRAND-DES registry. EuroIntervention. 2021;16(16):1318\u201325. https:\/\/doi.org\/10.4244\/EIJ-D-19-00296.","journal-title":"EuroIntervention"},{"issue":"9","key":"3110_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/J.JACC.2008.04.056","volume":"52","author":"SW Lee","year":"2008","unstructured":"Lee SW, Park SW, Kim YH, et al. A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol. 2008;52(9):727\u201333. https:\/\/doi.org\/10.1016\/J.JACC.2008.04.056.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3110_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/J.AHJ.2011.07.003","volume":"162","author":"S Kufner","year":"2011","unstructured":"Kufner S, De Waha A, Tomai F, et al. A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease. Am Heart J. 2011;162(4):740\u20137. https:\/\/doi.org\/10.1016\/J.AHJ.2011.07.003.","journal-title":"Am Heart J"},{"issue":"6","key":"3110_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/EURHEARTJ\/EHN021","volume":"29","author":"M Billinger","year":"2008","unstructured":"Billinger M, Beutler J, Taghetchian KR, et al. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J. 2008;29(6):718\u201325. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHN021.","journal-title":"Eur Heart J"},{"issue":"25","key":"3110_CR44","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/J.JACC.2010.10.006","volume":"56","author":"DJ Kereiakes","year":"2010","unstructured":"Kereiakes DJ, Cutlip DE, Applegate RJ, et al. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical evaluation of the XIENCE V everolimus eluting coronary stent System). J Am Coll Cardiol. 2010;56(25):2084\u20139. https:\/\/doi.org\/10.1016\/J.JACC.2010.10.006.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"3110_CR45","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/JAMA.299.16.1903","volume":"299","author":"GW Stone","year":"2008","unstructured":"Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008;299(16):1903\u201313. https:\/\/doi.org\/10.1001\/JAMA.299.16.1903.","journal-title":"JAMA"},{"issue":"23","key":"3110_CR46","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1016\/J.JCIN.2023.09.026","volume":"16","author":"K Ninomiya","year":"2023","unstructured":"Ninomiya K, Serruys PW, Colombo A, et al. A prospective randomized trial comparing Sirolimus-Coated balloon with Paclitaxel-Coated balloon in de Novo small vessels. JACC Cardiovasc Interv. 2023;16(23):2884\u201396. https:\/\/doi.org\/10.1016\/J.JCIN.2023.09.026.","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"3110_CR47","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.4244\/EIJ-D-23-00966","volume":"20","author":"PP Leone","year":"2024","unstructured":"Leone PP, Heang TM, Yan LC, et al. Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE registry. EuroIntervention. 2024;20(13):e831\u20133. https:\/\/doi.org\/10.4244\/EIJ-D-23-00966.","journal-title":"EuroIntervention"},{"key":"3110_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/S12933-024-02139-9","author":"G Caiazzo","year":"2024","unstructured":"Caiazzo G, Oliva A, Testa L et al Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry. Cardiovasc Diabetol. 2024. https:\/\/doi.org\/10.1186\/S12933-024-02139-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3110_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/CCD.30358","volume":"100","author":"A Greco","year":"2022","unstructured":"Greco A, Sciahbasi A, Abizaid A, et al. Sirolimus-coated balloon versus everolimus-eluting stent in de Novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial. Catheter Cardiovasc Interv. 2022;100(4):544\u201352. https:\/\/doi.org\/10.1002\/CCD.30358.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03110-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:57:02Z","timestamp":1775127422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03110-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3110"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03110-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies complied with the Declaration of Helsinki, were conducted in accordance with local Institutional Review Board requirements, and all patients provided informed consent for the procedure and subsequent data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}